Clinical Effects of Sodium-Glucose Transporter Type 2 Inhibitors in Patients With Partial Lipodystrophy

Bansal et al.

Endocr Pract. 2022 Mar 14;S1530-891X(22)00086-6.

DOI: 10.1016/j.eprac.2022.03.006. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/35301125/